DEBORAH DING: Open Payments
NPI 1689805129 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 68 payments from 27 companies in 2025. Trend: 2023 $1,311 · 2024 $1,146 · 2025 $1,450
Food & beverage: $1,374Education: $76
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $264 |
| E.R. Squibb & Sons, L.L.C. | 10 | $187 |
| Novartis Pharmaceuticals Corporation | 6 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| SEAGEN INC. | 1 | $76 |
| PFIZER INC. | 5 | $71 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| SpringWorks Therapeutics, Inc. | 2 | $42 |
| BeOne Medicines USA, Inc. | 2 | $38 |
Products named: OPDIVO, Enhertu, Fabhalta, CALQUENCE, LYNPARZA, KEYTRUDA, IMFINZI, XTANDI.
Industry payments across AL — which companies pay providers there.
